Liquid Biopsy Confirms Complete Remission in Rare Mediastinal Seminoma Case
Oncologists documented circulating tumor DNA clearance and complete metabolic response in a patient with a rare marker-negative mediastinal seminoma harboring ...
Oncologists documented circulating tumor DNA clearance and complete metabolic response in a patient with a rare marker-negative mediastinal seminoma harboring ...
Researchers developed an EORTC custom questionnaire tracking 50 symptoms in chronic myeloid leukemia, finding significant toxicity variations among common kinase ...
Researchers have found that the breast cancer drug abemaciclib suppresses tumor growth and halts signaling in preclinical lung cancer models ...
A single-center retrospective study linked multi-target TKIs plus immunotherapy to longer survival than bevacizumab regimens in advanced hepatocellular carcinoma.
A meta-analysis of 31 studies demonstrates that combining transarterial chemoembolization with targeted anti-VEGF agents and immune checkpoint inhibitors significantly extends ...
A decision-tree simulation shows that pathologist-initiated reflex testing for non-small cell lung cancer improves survival while lowering annual healthcare expenditures ...
A 20-year retrospective pharmacovigilance study of FAERS data identified 31,911 reports of tyrosine kinase inhibitor cardiotoxicity characterized by class-specific adverse ...
A case report documents nine months of stable disease in a patient with metastatic GIST treated with pembrolizumab after failing ...
Researchers have discovered that the RNA-binding protein HuR promotes lenvatinib resistance in hepatocellular carcinoma by stabilizing GPX4 and repressing ferroptotic ...
A systematic review and meta-analysis of 25 clinical trials found that MET tyrosine kinase inhibitors achieved a 49 percent objective ...
A disproportionality analysis of the FDA Adverse Event Reporting System reveals distinct cutaneous toxicity signals between immune checkpoint inhibitors and ...
A newly reported clinical case describes the concurrent baseline presence of the Philadelphia chromosome, del(5q), and monosomy 7 in accelerated-phase ...
A phase 2 basket trial found oral ponatinib did not meet its primary endpoint in solid tumors with FGFR alterations, ...
A systematic review indicates that the allosteric inhibitor asciminib achieves superior molecular response rates and lower treatment discontinuation compared to ...
Clinicians have reported a case of probable Stevens–Johnson syndrome linked to taletrectinib in a patient with ROS1-positive non-small cell lung ...
A multicenter retrospective study of 54 patients found that lorlatinib significantly extended progression-free survival compared to earlier-generation inhibitors in ALK ...
A retrospective Tanzanian study of 60 CD117-positive gastrointestinal stromal tumors found that 12 cases, or 20.0 percent, were SDHB-negative, with ...
A retrospective study of 250 patients developed a nomogram using age, EGFR genotype, CYFRA21-1 level, and TKI generation to predict ...
A new review examines how chemotherapeutic agents damage sperm DNA and germ cells, and what fertility preservation options exist for ...
A scoping review of 14 studies finds that nurse-led education, continuity-of-care programs, and telehealth monitoring are the main strategies for ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.